• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性颅内高压的研究重点是什么?患者和医疗保健专业人员之间的优先事项设定伙伴关系。

What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals.

机构信息

Department of Birmingham Neuro-Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

IIH UK, Tyne and Wear, UK.

出版信息

BMJ Open. 2019 Mar 15;9(3):e026573. doi: 10.1136/bmjopen-2018-026573.

DOI:10.1136/bmjopen-2018-026573
PMID:30878991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6429891/
Abstract

OBJECTIVE

Idiopathic intracranial hypertension (IIH) is under-researched and the aim was to determine the top 10 research priorities for this disease.

DESIGN

A modified nominal group technique was used to engage participants who had experience of IIH.

SETTING

This James Lind Alliance Priority Setting Partnership was commissioned by IIH UK, a charity.

PARTICIPANTS

People with IIH, carers, family and friends, and healthcare professionals participated in two rounds of surveys to identify unique research questions unanswered by current evidence. The most popular 26 uncertainties were presented to stakeholders who then agreed the top 10 topics.

RESULTS

The top 10 research priorities for IIH included aetiology of IIH, the pathological mechanisms of headache in IIH, new treatments in IIH, the difference between acute and gradual visual loss, the best ways to monitor visual function, biomarkers of the disease, hormonal causes of IIH, drug therapies for the treatment of headache, weight loss and its role in IIH and finally, the best intervention to treat IIH and when should surgery be performed.

CONCLUSIONS

This priority setting encouraged people with direct experience of IIH to collectively identify critical gaps in the existing evidence. The overarching research aspiration was to understand the aetiology and management of IIH.

摘要

目的

特发性颅内高压(IIH)研究不足,本研究旨在确定该疾病的前 10 项研究重点。

设计

采用改良名义团体技术,让具有 IIH 经验的参与者参与。

背景

该 James Lind 联盟优先事项设定伙伴关系由 IIH UK(一家慈善机构)委托进行。

参与者

IIH 患者、护理人员、家属和朋友以及医疗保健专业人员参与了两轮调查,以确定当前证据未回答的独特研究问题。将最受欢迎的 26 个不确定因素提交给利益相关者,然后由他们确定前 10 个主题。

结果

IIH 的前 10 项研究重点包括 IIH 的病因、IIH 头痛的病理机制、IIH 的新治疗方法、急性和逐渐视力丧失之间的差异、监测视觉功能的最佳方法、疾病的生物标志物、IIH 的激素原因、用于治疗头痛的药物治疗、减肥及其在 IIH 中的作用以及治疗 IIH 的最佳干预措施和何时应进行手术。

结论

这项优先事项的设定鼓励具有 IIH 直接经验的人共同确定现有证据中的关键差距。首要的研究愿望是了解 IIH 的病因和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e7/6429891/e3c1faca7782/bmjopen-2018-026573f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e7/6429891/9c08b11dc2cc/bmjopen-2018-026573f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e7/6429891/e3c1faca7782/bmjopen-2018-026573f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e7/6429891/9c08b11dc2cc/bmjopen-2018-026573f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1e7/6429891/e3c1faca7782/bmjopen-2018-026573f02.jpg

相似文献

1
What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals.特发性颅内高压的研究重点是什么?患者和医疗保健专业人员之间的优先事项设定伙伴关系。
BMJ Open. 2019 Mar 15;9(3):e026573. doi: 10.1136/bmjopen-2018-026573.
2
Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease.确定帕金森病管理十大研究重点的优先事项设定伙伴关系。
BMJ Open. 2014 Dec 14;4(12):e006434. doi: 10.1136/bmjopen-2014-006434.
3
Identifying and prioritising unanswered research questions for people with hyperacusis: James Lind Alliance Hyperacusis Priority Setting Partnership.确定和优先考虑患有听觉过敏症人群的未解决研究问题:詹姆斯林德联盟听觉过敏优先事项设定伙伴关系。
BMJ Open. 2019 Nov 21;9(11):e032178. doi: 10.1136/bmjopen-2019-032178.
4
Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance.肝糖原贮积病的研究重点:与詹姆斯·林德联盟的国际优先事项确定合作项目
J Inherit Metab Dis. 2020 Mar;43(2):279-289. doi: 10.1002/jimd.12178. Epub 2019 Nov 13.
5
Identifying Priorities for Physiotherapy Research in the UK: the James Lind Alliance Physiotherapy Priority Setting Partnership.确定英国物理治疗研究重点:詹姆斯·林德联盟物理治疗重点制定伙伴关系。
Physiotherapy. 2020 Jun;107:161-168. doi: 10.1016/j.physio.2019.07.006. Epub 2019 Jul 29.
6
Setting research priorities to improve the health of children and young people with neurodisability: a British Academy of Childhood Disability-James Lind Alliance Research Priority Setting Partnership.确定研究重点,以改善患有神经残疾的儿童和年轻人的健康:英国儿童残疾学会-詹姆斯·林德联盟研究重点制定伙伴关系。
BMJ Open. 2015 Jan 28;5(1):e006233. doi: 10.1136/bmjopen-2014-006233.
7
Research priorities for the management of broken bones of the upper limb in people over 50: a UK priority setting partnership with the James Lind Alliance.50 岁以上人群上肢骨折管理的研究重点:英国与詹姆斯林德联盟的优先事项设定伙伴关系。
BMJ Open. 2019 Dec 15;9(12):e030028. doi: 10.1136/bmjopen-2019-030028.
8
Research priorities for pregnancy hypertension: a UK priority setting partnership with the James Lind Alliance.妊娠高血压研究重点:英国与詹姆斯林德联盟的优先事项设定伙伴关系。
BMJ Open. 2020 Jul 14;10(7):e036347. doi: 10.1136/bmjopen-2019-036347.
9
Research priorities in foot and ankle conditions: results of a UK priority setting partnership with the James Lind Alliance.足部和踝关节疾病的研究重点:英国与詹姆斯林德联盟合作的优先事项设定结果。
BMJ Open. 2023 May 16;13(5):e070641. doi: 10.1136/bmjopen-2022-070641.
10
Dementia priority setting partnership with the James Lind Alliance: using patient and public involvement and the evidence base to inform the research agenda.与詹姆斯·林德联盟合作开展的痴呆症研究优先级设定:利用患者和公众参与以及证据基础为研究议程提供信息。
Age Ageing. 2015 Nov;44(6):985-93. doi: 10.1093/ageing/afv143.

引用本文的文献

1
A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertension.一项随机序贯交叉试验,评估五种据称可降低颅内压的药物在特发性颅内高压中的疗效。
Headache. 2025 Feb;65(2):258-268. doi: 10.1111/head.14897. Epub 2025 Jan 24.
2
Managing idiopathic intracranial hypertension in the eye clinic.在眼科门诊管理特发性颅内高压。
Eye (Lond). 2024 Aug;38(12):2472-2481. doi: 10.1038/s41433-024-03140-y. Epub 2024 May 24.
3
Navigating the Enigma: A Comprehensive Review of Idiopathic Intracranial Hypertension.

本文引用的文献

1
Advances in the understanding of headache in idiopathic intracranial hypertension.特发性颅内高压性头痛的研究进展。
Curr Opin Neurol. 2019 Feb;32(1):92-98. doi: 10.1097/WCO.0000000000000651.
2
Stent Survival and Stent-Adjacent Stenosis Rates following Venous Sinus Stenting for Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis.特发性颅内高压患者静脉窦支架置入术后的支架生存率及支架邻近狭窄率:一项系统评价和Meta分析
Interv Neurol. 2018 Oct;7(6):490-500. doi: 10.1159/000490578. Epub 2018 Jul 31.
3
The expanding burden of idiopathic intracranial hypertension.
解读谜团:特发性颅内高压的全面综述
Cureus. 2024 Mar 16;16(3):e56256. doi: 10.7759/cureus.56256. eCollection 2024 Mar.
4
Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension.GLP-1 受体激动剂艾塞那肽作为降颅压药物对特发性颅内高压认知功能的影响。
Eye (Lond). 2024 May;38(7):1374-1379. doi: 10.1038/s41433-023-02908-y. Epub 2024 Jan 11.
5
Weight management communications in idiopathic intracranial hypertension: challenges and recommendations from the patients' perspective.特发性颅内高压的体重管理沟通:患者视角的挑战与建议
BMJ Neurol Open. 2023 Dec 9;5(2):e000527. doi: 10.1136/bmjno-2023-000527. eCollection 2023.
6
Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms.特发性颅内高压:对疾病机制认识的重大改变。
Nat Rev Neurol. 2023 Dec;19(12):769-785. doi: 10.1038/s41582-023-00893-0. Epub 2023 Nov 13.
7
Weight Management Interventions for Adults With Idiopathic Intracranial Hypertension: A Systematic Review and Practice Recommendations.特发性颅内高压成人的体重管理干预措施:系统评价和实践建议。
Neurology. 2023 Nov 21;101(21):e2138-e2150. doi: 10.1212/WNL.0000000000207866. Epub 2023 Oct 9.
8
Author Response: Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension.作者回复:减肥手术后体重减轻量与特发性颅内高压女性颅内压的关联
Neurology. 2023 Mar 14;100(11):543. doi: 10.1212/WNL.0000000000207120.
9
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial.利拉鲁肽对特发性颅内高压的影响:一项随机临床试验。
Brain. 2023 May 2;146(5):1821-1830. doi: 10.1093/brain/awad003.
10
Different Characteristics of Pre-Pubertal and Post-Pubertal Idiopathic Intracranial Hypertension: A Narrative Review.青春期前和青春期后特发性颅内高压的不同特征:一项叙述性综述
Neuroophthalmology. 2022 Dec 15;47(2):63-74. doi: 10.1080/01658107.2022.2153874. eCollection 2023.
特发性颅内高压负担日益加重。
Eye (Lond). 2019 Mar;33(3):478-485. doi: 10.1038/s41433-018-0238-5. Epub 2018 Oct 24.
4
European headache federation guideline on idiopathic intracranial hypertension.欧洲头痛联合会特发性颅内高压指南。
J Headache Pain. 2018 Oct 8;19(1):93. doi: 10.1186/s10194-018-0919-2.
5
Raised intracranial pressure in those presenting with headache.头痛患者颅内压升高。
BMJ. 2018 Oct 4;363:k3252. doi: 10.1136/bmj.k3252.
6
Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention.特发性颅内高压的代谢概念及其治疗干预的潜力。
J Neuroophthalmol. 2018 Dec;38(4):522-530. doi: 10.1097/WNO.0000000000000684.
7
Idiopathic intracranial hypertension: consensus guidelines on management.特发性颅内高压:管理共识指南。
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1088-1100. doi: 10.1136/jnnp-2017-317440. Epub 2018 Jun 14.
8
Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey.描述特发性颅内高压患者腰椎穿刺诊断的体验:一项横断面在线调查。
BMJ Open. 2018 May 30;8(5):e020445. doi: 10.1136/bmjopen-2017-020445.
9
Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol.减肥手术与社区减肥计划对特发性颅内高压持续治疗的随机对照试验:特发性颅内高压体重试验(IIH:WT)方案
BMJ Open. 2017 Sep 27;7(9):e017426. doi: 10.1136/bmjopen-2017-017426.
10
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.在特发性颅内高压药物试验IIH:DT中评估11β-羟类固醇脱氢酶1型抑制剂(AZD4017)的疗效和安全性:一项II期随机对照试验的临床方法与设计
JMIR Res Protoc. 2017 Sep 18;6(9):e181. doi: 10.2196/resprot.7806.